Nanoform Finland Plc (NANOFH) - Total Liabilities
Based on the latest financial reports, Nanoform Finland Plc (NANOFH) has total liabilities worth €12.56 Million EUR (≈ $14.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NANOFH cash generation efficiency to assess how effectively this company generates cash.
Nanoform Finland Plc - Total Liabilities Trend (2016–2024)
This chart illustrates how Nanoform Finland Plc's total liabilities have evolved over time, based on quarterly financial data. Check Nanoform Finland Plc (NANOFH) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Nanoform Finland Plc Competitors by Total Liabilities
The table below lists competitors of Nanoform Finland Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grong Sparebank
OL:GRONG
|
Norway | Nkr10.05 Billion |
|
Sempio Foods Co
KO:248170
|
Korea | ₩132.99 Billion |
|
Clene Inc.
NASDAQ:CLNN
|
USA | $35.72 Million |
|
Bound and Beyond PCL
BK:BEYOND
|
Thailand | ฿6.75 Billion |
|
Hyundai E P
KO:089470
|
Korea | ₩317.54 Billion |
|
Flexible Solutions International Inc
NYSE MKT:FSI
|
USA | $19.00 Million |
|
ProfilGruppen AB (publ)
ST:PROF-B
|
Sweden | Skr752.50 Million |
|
MAG Holdings Berhad
KLSE:0095
|
Malaysia | RM496.75 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Nanoform Finland Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Nanoform Finland Plc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanoform Finland Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanoform Finland Plc (2016–2024)
The table below shows the annual total liabilities of Nanoform Finland Plc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €11.77 Million ≈ $13.77 Million |
+5.24% |
| 2023-12-31 | €11.19 Million ≈ $13.08 Million |
-16.69% |
| 2022-12-31 | €13.43 Million ≈ $15.70 Million |
-9.63% |
| 2021-12-31 | €14.86 Million ≈ $17.37 Million |
+32.07% |
| 2020-12-31 | €11.25 Million ≈ $13.15 Million |
+126.01% |
| 2019-12-31 | €4.98 Million ≈ $5.82 Million |
+56.78% |
| 2018-12-31 | €3.18 Million ≈ $3.71 Million |
+205.34% |
| 2017-12-31 | €1.04 Million ≈ $1.22 Million |
+82.31% |
| 2016-12-31 | €570.41K ≈ $666.87K |
-- |
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) na… Read more